BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9438780)

  • 1. Dose-dependent effect of octreotide on insulin secretion after OGTT in obesity.
    Bertoli A; Magnaterra R; Borboni P; Marini MA; Barini A; Fusco A; Bollea MR
    Horm Res; 1998; 49(1):17-21. PubMed ID: 9438780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of long-acting release octreotide on glucose homeostasis in acromegaly patients after trans-sphenoidal surgery.
    Chen HS; Wu TE; Jap TS; Hsiao LC; Lin HD; Lee SH; Lin SH
    Horm Metab Res; 2011 Jun; 43(6):433-9. PubMed ID: 21538290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute and chronic effects of dexfenfluramine on glucose and insulin response to intravenous glucose in diabetic and non-diabetic obese subjects.
    Glaser B; Raveh Y; Norynberg C; Berry E; Lavielle R; Nathan C; Cerasi E
    Diabetes Res; 1992; 19(4):165-76. PubMed ID: 1343113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicenter, randomized, double-blind, placebo-controlled, dose-finding trial of a long-acting formulation of octreotide in promoting weight loss in obese adults with insulin hypersecretion.
    Lustig RH; Greenway F; Velasquez-Mieyer P; Heimburger D; Schumacher D; Smith D; Smith W; Soler N; Warsi G; Berg W; Maloney J; Benedetto J; Zhu W; Hohneker J
    Int J Obes (Lond); 2006 Feb; 30(2):331-41. PubMed ID: 16158082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin sensitivity and first-phase insulin secretion in obese Chinese with hyperglycemia in 30 and/or 60 min during glucose tolerance tests.
    Hong J; Zhang YF; Gu WQ; Zhang YW; Su YX; Chi ZN; Wang WQ; Li XY; Ning G
    Endocrine; 2008; 34(1-3):75-80. PubMed ID: 18979203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinol-binding protein 4 is associated with impaired glucose tolerance but not with whole body or hepatic insulin resistance in Mexican Americans.
    Chavez AO; Coletta DK; Kamath S; Cromack DT; Monroy A; Folli F; DeFronzo RA; Tripathy D
    Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E758-64. PubMed ID: 19190263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin secretory responses to rising and falling glucose concentrations are delayed in subjects with impaired glucose tolerance.
    Ehrmann DA; Breda E; Cavaghan MK; Bajramovic S; Imperial J; Toffolo G; Cobelli C; Polonsky KS
    Diabetologia; 2002 Apr; 45(4):509-17. PubMed ID: 12032626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the effects of pegvisomant and octreotide on glucose, insulin, gastrin, cholecystokinin, and pancreatic polypeptide responses to oral glucose and a standard mixed meal.
    Parkinson C; Drake WM; Roberts ME; Meeran K; Besser GM; Trainer PJ
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1797-804. PubMed ID: 11932320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of insulin secretion and insulin sensitivity between normal and impaired glucose tolerance subjects with normal fasting plasma glucose.
    Tang KT; Ho LT; Jap TS; Chang TC; Ching KN; Lam HC; Wu MS; Lee SP
    Zhonghua Yi Xue Za Zhi (Taipei); 1990 Aug; 46(2):73-8. PubMed ID: 2177367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired early- but not late-phase insulin secretion in subjects with impaired fasting glucose.
    Kanat M; Norton L; Winnier D; Jenkinson C; DeFronzo RA; Abdul-Ghani MA
    Acta Diabetol; 2011 Sep; 48(3):209-17. PubMed ID: 21553243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A study of the degrees of insulin resistance and first-phase insulin secretion of beta-cells in metabolic syndrome patients with different glucose tolerance].
    Hong J; Gu WQ; Zhang YF; Guo Y; Chen HM; Zhang LZ; Zhao YJ; Ning G
    Zhonghua Yi Xue Za Zhi; 2003 Nov; 83(22):1952-6. PubMed ID: 14703429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood Glucose and Insulin Concentrations after Octreotide Administration in Horses With Insulin Dysregulation.
    Frank N; Hermida P; Sanchez-Londoño A; Singh R; Gradil CM; Uricchio CK
    J Vet Intern Med; 2017 Jul; 31(4):1188-1192. PubMed ID: 28503791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothalamic obesity caused by cranial insult in children: altered glucose and insulin dynamics and reversal by a somatostatin agonist.
    Lustig RH; Rose SR; Burghen GA; Velasquez-Mieyer P; Broome DC; Smith K; Li H; Hudson MM; Heideman RL; Kun LE
    J Pediatr; 1999 Aug; 135(2 Pt 1):162-8. PubMed ID: 10431109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laparoscopic sleeve gastrectomy for diabetes treatment in nonmorbidly obese patients: efficacy and change of insulin secretion.
    Lee WJ; Ser KH; Chong K; Lee YC; Chen SC; Tsou JJ; Chen JC; Chen CM
    Surgery; 2010 May; 147(5):664-9. PubMed ID: 20004451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of soy protein isolate preload on postprandial glycemic control in healthy humans.
    Kashima H; Uemoto S; Eguchi K; Endo MY; Miura A; Kobayashi T; Fukuba Y
    Nutrition; 2016 Sep; 32(9):965-9. PubMed ID: 27157469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Massive weight loss does not restore normal insulin secretory pulses in obese patients with type 2 (non-insulin-dependent) diabetes mellitus.
    Guichard-Rode S; Charrie A; Penet D; Teboul F; Thivolet C
    Diabetes Metab; 1997 Dec; 23(6):506-10. PubMed ID: 9496556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of octreotide on glucose tolerance in acromegaly.
    Koop BL; Harris AG; Ezzat S
    Eur J Endocrinol; 1994 Jun; 130(6):581-6. PubMed ID: 8205258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycemic profile in patients with acromegaly treated with somatostatin analogue.
    Valea A; Carsote M; Ghervan C; Georgescu C
    J Med Life; 2015; 8 Spec Issue(Spec Issue):82-6. PubMed ID: 26361517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-response study and long term effect of the somatostatin analog octreotide in patients with therapy-resistant acromegaly.
    Quabbe HJ; Plöckinger U
    J Clin Endocrinol Metab; 1989 May; 68(5):873-81. PubMed ID: 2565912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The somatostatin analogue SOM230, compared with octreotide, induces differential effects in several metabolic pathways in acromegalic patients.
    van der Hoek J; van der Lelij AJ; Feelders RA; de Herder WW; Uitterlinden P; Poon KW; Boerlin V; Lewis I; Krahnke T; Hofland LJ; Lamberts SW
    Clin Endocrinol (Oxf); 2005 Aug; 63(2):176-84. PubMed ID: 16060911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.